Author： Cutsem E.V.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.7, Iss.5, 1998-05, pp. : 823-834
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Indirect costs lower with raltitrexed
Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. :
Clinical and Preclinical Pharmacokinetics of Raltitrexed
By Clarke S.J.
Clinical Pharmacokinetics, Vol. 39, Iss. 6, 2000-12 ,pp. :
Indirect costs lower with raltitrexed
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 267, 2000-01 ,pp. :
Raltitrexed + cisplatin stabilise HRQOL in mesothelioma
Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. :